Renalytix announces LCD open meeting for kidneyIntelX.dkd; potential coverage for 5M more Medicare patients

Renalytix plc

NGS LCD Open Meeting scheduled for February 29, 2024 to discuss coverage of KidneyIntelX and kidneyintelX.dkd.
Proposed LCDs published February 8, 2024; 45-day public comment period ends March 23, 2024.
If covered, an estimated additional 5 million Medicare patients with Type 2 diabetes and early-stage CKD could gain access.
New private payer contract with Velocity National Provider Network, covering 2.7 million member lives, effective January 2024.
Final LCD expected during calendar year 2024 after public comment review.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.